New research has discovered that smoking and oral sex are tied to an increased risk of developing HPV-related oropharyngeal cancer, which is a form of head and neck cancer activated by exposure to the human papillomavirus (HPV).Although the risk is increased, it is still low; only 0.7 percent of men are ever likely developing oropharyngeal cancer during their lifetimes, according to the new study.The risk of developing the condition was found to be considerably lower among women, non-smokers, and those who had had fewer than five partners with whom they had performed oral sex.Prof. Gypsyamber D'Souza, of the Johns Hopkins Bloomberg School of Public Health, and Dr. Carole Fakhry, of the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery — both of which are located in Baltimore, MD — conducted the research.
Their results have been published in the journal Annals of Oncology.Every year in the United States, there are approximately 16,500 cases of oropharyngeal squamous cell carcinoma, which is the most common type of oropharyngeal cancer. More than 11,500 of these are HPV-related.
More than 100 different types of HPV exist, but only a few of these are known to cause cancer. HPV16 or 18, for example, triggers most cases of cervical cancer, and HPV16 is known to cause most oropharyngeal cancers.
Experts have predicted that by 2020, the incidence of oropharyngeal cancer will overtake that of cervical cancer."For these reasons," says Prof. D'Souza, "it would be useful to be able to identify healthy people who are most at risk of developing oropharyngeal cancer in order to inform potential screening strategies, if effective screening tests could be developed."She adds, "Most people perform oral sex in their lives, and we found that oral infection with cancer-causing HPV was rare among women regardless of how many oral sex partners they had.""Among men who did not smoke," Prof. D'Souza says, "cancer-causing oral HPV was rare among everyone who had less than five oral sex partners, although the chances of having oral HPV infection did increase with number of oral sexual partners, and with smoking."The study data came from 13,089 individuals, all of whom were aged 20–69 years old, who took part in the National Health and Nutrition Examination Survey.The participants had all been tested for oral HPV infection. To predict the risk of oropharyngeal cancer from oral HPV infection, the researchers used data on oropharyngeal cancer cases and deaths from U.S. registries.
Smoking and oral sex partners elevate risk
Prof. D'Souza and Dr. Fakhry found the lowest prevalence of oral infection with cancer-causing forms of HPV in women who had had one or no oral sex partners during their lifetimes.
Of these, 1.8 percent were smokers and 0.5 percent were non-smokers. The risk of infection climbed slightly to 1.5 percent for women who had had two to more oral sex partners.
Among men, those who had had one or no oral sex partners were at the lowest risk, with a prevalence of 1.5 percent for oral HPV infection. Among men with two to four oral sex partners, prevalence increased to 4 percent among non-smokers and elevated further to 7.1 percent among men who smoked.
Non-smoking men who had had five or more oral sex partners had a prevalence of oral HPV infection of 7.4 percent. The highest prevalence of infection — reaching 15 percent — was observed among men with five or more oral sex partners and who smoked.
Continue reading.. Could oral sex raise your head and neck cancer risk? [...]
A survey of thousands of men - including more than 500 in Scotland - found only 8% know what the prostate does while only half know where it is in the body. Angela Culhane, chief executive of Prostate Cancer UK, said: "Ignoring your prostate can be lethal. [...]
There is currently no cure for psoriatic arthritis, but treatment options are available. Medical treatments involve the use of anti-inflammatory medications, disease-modifying anti-rheumatic drugs (which slow down disease progression ... [...]
(HealthDay News) -- Breast cancer patients fond of midnight snacking may be at a higher risk of a breast cancer recurrence, according to new research. "Women whose usual nightly fast was less than 13 hours had a 36 percent increased risk of having a ... [...]
A woman treated for breast cancer is backing a campaign to raise £1m towards vital research. Sue Stannard. Sue Stannard is supporting The University of Nottingham's Breast Cancer Research fundraising campaign. Sue, of Caythorpe, Notting-hamshire, was ... [...]
Those who do sneak a peek will get an eyeful along with a sobering message about breast cancer. Inside the peepholes are three glossy black mannequins in pink wigs with facts like "every 2 minutes a woman is diagnosed with breast cancer" painted across ... [...]
Prostate cancer treatment The prostate cancer 2016 update has thrown a new light on the link between colon cancer and radiation, and hormone therapy for prostate cancer treatment. According to a new research, treatment of prostate cancer via radiation ... [...]
Saturday at 8 a.m., more than 300 walkers assembled at the St. James City Civic Association for the annual walk to beat breast cancer. "Our mission is to help in the fight to find a cure for the debilitating disease of breast cancer and help those ... [...]
“I find it terrifying and very hard to come to terms with the fact that no one can tell me what has caused my tumour,” the father-of-two told The Hunts Post. Steve suffered his first symptoms – a headache and poor vision – during the Milton Keynes half ... [...]
The Natural Dentist® was launched in 1995. The launch was led with The Natural Dentist Healthy Gums® Antigingivisis Rinse, developed by a dentist seeking to offer his patients effective and natural protection against gingivitis, an early indicator of ... [...]
They vowed to continue his fight for increased awareness and research funding. The women founded Shining Down, Inc., not only as a way to channel their tremendous grief into a positive outlet by funding more prostate cancer treatment research, but to ... [...]
TNF is a proinflammatory cytokine that plays a pivotal role in regulating the inflammatory response in RA, and TNF inhibitors are often prescribed to RA patients. However, recent reports highlight a potential increased risk of patients treated with TNF ... [...]